Resultados de la búsqueda 431-440 of 5745 for 남양주건마🔥 ┎OPdal040.COM】오피달리기 👫남양주아로마🏑남양주OP😬남양주마사지👑남양주립카페🔧남양주출장안마🔭남양주대딸방🌽

  1. Oncología (médica) - Ensayos clínicos

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  2. Obstetricia y Ginecología - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to assemble a collection of serial plasma biospecimens from women with ovarian, primary peritoneal, or fallopian ...

  3. Oncología (médica) - Ensayos clínicos

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL.

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the detection of ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...

  7. Cáncer de próstata - Médicos y departamentos - Mayo Clinic

    Obtén información sobre la detección, los enfoques de diagnóstico, las opciones de tratamiento y los avances relacionados con el cáncer de próstata, ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this trial is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) ...

  10. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...